MEDAVAIL HOLDINGS INC's ticker is MDVL and the CUSIP is 58406B103. A total of 51 filers reported holding MEDAVAIL HOLDINGS INC in Q1 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,735 | -14.5% | 15,237 | 0.0% | 0.00% | -100.0% |
| Q1 2023 | $4,367 | -4.4% | 15,237 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $4,568 | -61.9% | 15,237 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $12,000 | -47.8% | 15,237 | 0.0% | 0.00% | -33.3% |
| Q2 2022 | $23,000 | +53.3% | 15,237 | 0.0% | 0.00% | +200.0% |
| Q1 2022 | $15,000 | -28.6% | 15,237 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $21,000 | -52.3% | 15,237 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $44,000 | -76.5% | 15,237 | 0.0% | 0.00% | -73.3% |
| Q2 2021 | $187,000 | -12.2% | 15,237 | 0.0% | 0.02% | -11.8% |
| Q1 2021 | $213,000 | -7.0% | 15,237 | 0.0% | 0.02% | -10.5% |
| Q4 2020 | $229,000 | – | 15,237 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 15,029,480 | $22,995,000 | 81.12% |
| Ally Bridge Group (NY) LLC | 5,894,897 | $9,019,000 | 8.22% |
| Redmile Group, LLC | 25,192,751 | $38,545,000 | 1.47% |
| CIGNA INVESTMENTS INC /NEW | 2,389,478 | $3,656,000 | 0.73% |
| Alyeska Investment Group, L.P. | 7,529,411 | $11,520,000 | 0.13% |
| PURA VIDA INVESTMENTS, LLC | 714,120 | $1,093,000 | 0.06% |
| Alpha Paradigm Partners, LLC | 57,539 | $88,000,000 | 0.04% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 836,626 | $1,280,000 | 0.03% |
| Belvedere Trading LLC | 242,100 | $332,000 | 0.01% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,000,000 | $1,530,000 | 0.00% |